The oral clearance and β-adrenoceptor antagonist activity of propranolol after single dose are not related to debrisoquine oxidation phenotype

Similar Items

• The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol.
  od: Lennard, M S, i dr.
  Izdano: (1984)
• Polymorphic metabolism of β-adrenoceptor antagonists
  od: Silas, J. H., i dr.
  Izdano: (1984)
• The effect of β-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin
  od: Bax, N. D. S., i dr.
  Izdano: (1984)
• Effects of β-adrenoceptor antagonists on the pharmacokinetics of lignocaine
  od: Tucker, G. T., i dr.
  Izdano: (1984)
• The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.
  od: Bax, N D, i dr.
  Izdano: (1984)